| 000 | 03133nam a22003735i 4500 | ||
|---|---|---|---|
| 001 | 100315 | ||
| 003 | DE-He213 | ||
| 005 | 20230110040212.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 180413s2018 gw | s |||| 0|eng d | ||
| 020 |
_a9783319735061 _9 |
||
| 024 | 7 |
_a10.1007/978-3-319-73506-1 _2doi |
|
| 040 |
_aES-MaUEC _bspa |
||
| 050 | 4 | _aRC182.S4 2018 EB | |
| 245 | 1 | 0 |
_aHandbook of Sepsis _cedited by W. Joost Wiersinga, Christopher W. Seymour. |
| 264 | 1 |
_aCham _bSpringer International Publishing _c2018 |
|
| 300 | _a1 recurso en línea (VIII, 267 páginas 22 ilustraciones, 19 ilustraciones a color) | ||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 505 | 0 | _aPART 1. SEPSIS: AN OVERVIEW:.-1. What is sepsis? -- 2. The epidemiology of sepsis -- PART 2. THE PATHOGENESIS OF SEPSIS: -- 3.The pathogenesis -- 4.The coagulation system in sepsis.-5.The endocrine system in sepsis -- 6.Biomarkers for sepsis -- PART 3.SEPSIS MANAGEMENT: -- 7.International clinical practice guidelines -- 8. Fluids -- 9.Vasopressors -- 10. Multiorgan failure -- 11.Importance of the pathogen -- 12.Antimicrobial therapy -- 13.Adjunctive immunotherapy -- PART IV. SEPSIS IN THE COMING DECADE: -- 14.Novel trial design in sepsis -- 15. Sepsis in low- and middle income countries -- 16 Sepsis: the road ahead. | |
| 520 | 3 | _aThis practically oriented book provides an up-to-date overview of all significant aspects of the pathogenesis of sepsis and its management, including within the intensive care unit. Readers will find information on the involvement of the coagulation and endocrine systems during sepsis and on the use of biomarkers to diagnose sepsis and allow early intervention. International clinical practice guidelines for the management of sepsis are presented, and individual chapters focus on aspects such as fluid resuscitation, vasopressor therapy, response to multiorgan failure, antimicrobial therapy, and adjunctive immunotherapy. The closing section looks forward to the coming decade, discussing novel trial designs, sepsis in low- and middle-income countries, and emerging management approaches. The book is international in scope, with contributions from leading experts worldwide. It will be of value to residents and professionals/practitioners in the fields of infectious diseases and internal medicine, as well as to GPs and medical students. | |
| 650 | 7 |
_aEnfermedades infecciosas _xDiagnóstico _9179353 _2embne |
|
| 650 | 7 |
_aSepticemia _9143089 _2embne |
|
| 700 | 1 |
_aWiersinga, W. Joost. _eeditor literario |
|
| 700 | 1 |
_aSeymour, Christopher W. _eeditor literario |
|
| 776 | 0 | 8 |
_iEdición impresa: _z9783319735054 |
| 776 | 0 | 8 |
_iEdición impresa: _z9783319735078 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-319-73506-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 490 | 0 | _aMedicine (Springer-11650) | |
| 988 | _aSpringer_Medicine_2018 | ||
| 998 |
_b01/2019 _dz _ea _feng _ggw _h0 |
||
| 999 |
_c100315 _d100315 _x1 |
||